Business Wire

MicroVention Announces 5-Year Clinical Trial Data and Size Additions for its WEB Aneurysm Embolization System; WEB is Most Well-Studied Intrasaccular Device Available Today

SAN DIEGO & ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year ...
La Grande Observer

Terumo Neuro Celebrates 15 Years of the WEB™ Device: A Game-Changing Innovation in Aneurysm Treatment

ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...
Nasdaq

Terumo (TRUMY) Unit Reveals WEB 17 Device Effective in Aneurysms

Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.
Business Wire

Global Vascular Embolization Devices Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Boston Scientific Corp. | Technavio | Business Wire

LONDON--(BUSINESS WIRE)--The global vascular embolization devices market is expected to grow by USD 1 billion during 2020-2024, progressing at a CAGR of almost 6% during the forecast period. The ...
Healio

Embolization device gains FDA 510(k) clearance

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Boston Scientific announced it received FDA 510(k) ...